Skip to content
OpenCapital
Get started

Century Therapeutics IPSC Q4 2025 Annual earnings

Reported March 12, 2026 · Before market open

Diluted EPS-$0.25Beat by $0.03
Revenue estimate-$62.5K
EPS estimate-$0.28

Next report

Aug 13, 2026 (in a month)
Revenue estimate$2.2M
EPS estimate-$0.11

Versus estimates

Revenue

Q1 2025$109.2MBeat by $67.9MQ4 2024$4.2MMiss by $45.4M

Diluted EPS

Q1 2026-$0.11Beat by $0.04
Q4 2025-$0.25Beat by $0.03
Q3 2025-$0.32Beat by $0.07Q2 2025-$0.38In lineQ1 2025$0.89Beat by $1.20Q4 2024-$0.43Beat by $0.02

Ask the moment Century Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Century Therapeutics report Q4 2025 earnings?
Century Therapeutics (IPSC) reported Q4 2025 earnings on March 12, 2026 before market open.
What were Century Therapeutics's Q4 2025 revenue and EPS?
Century Therapeutics reported diluted EPS of $-0.25 for Q4 2025.
Did Century Therapeutics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.28 by $0.03.
How did Century Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 41.9% from $-0.43.
Where can I find Century Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-026761) and the 10-K periodic report (0001104659-26-026759) directly on SEC EDGAR. The filing index links above go to sec.gov.